CompanyHealthAi
Kimia Therapeutics
Kimia Therapeutics is a Berkeley-based biotech building ATLAS, a drug-discovery platform that pairs nanoliter-scale high-throughput precision chemistry with machine learning and genome editing to map the druggable space at single-atom resolution. Spun out of Carmot Therapeutics in 2023 and backed by $55M in Series A funding, Kimia is using its chemical atlas to advance therapeutic programs in cancer and immunology.
2023Founded
BerkeleyHQ
$55MSeries A
biotechdrug-discoverymachine-learningprecision-chemistryhigh-throughput-screeningatlas-platform